Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial

European Journal of Nutrition

Volumn 54, Issue 1, 2015, Pages 89-99

  Sierra, Carlos ^a   Bernal, María José ^b   Blasco, Javier ^a   Martínez, Rosario ^b   Dalmau, Jaime ^c   Ortuño, Inmaculada ^b   Espín, Beatriz ^d   Vasallo, María Isabel ^b   Gil, David ^e   Vidal, María Luisa ^b   Infante, Dámaso ^f   Leis, Rosaura ^g   Maldonado, José ^h   Moreno, José Manuel ⁱ   Román, Enriqueta ^j  

^a HOSPITAL MATERNO INFANTIL   (Spain)

^b Research and Training Department   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g Instituto de Salud Carlos III   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

ⁱ HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^j HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

more..

Author keywords

Clinical trial; Infant formula; Infant nutrition; Prebiotics; Randomised double blind, placebo controlled study

Indexed keywords

4'-GALACTOOLIGOSACCHARIDE; ANTIALLERGIC AGENT; IMMUNOLOGIC FACTOR; OLIGOSACCHARIDE; PREBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; TRISACCHARIDE; VOLATILE FATTY ACID;

ARTIFICIAL MILK; BIFIDOBACTERIUM; CHEMISTRY; CLINICAL TRIAL; COHORT ANALYSIS; CONSTIPATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FECES; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYPERSENSITIVITY; INCIDENCE; INFANT; INFECTION; INNATE IMMUNITY; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SPAIN;

ANTI-ALLERGIC AGENTS; BIFIDOBACTERIUM; COHORT STUDIES; CONSTIPATION; DOUBLE-BLIND METHOD; FATTY ACIDS, VOLATILE; FECES; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; IMMUNOGLOBULIN A, SECRETORY; IMMUNOLOGIC FACTORS; INCIDENCE; INFANT; INFANT FORMULA; INFECTION; LOST TO FOLLOW-UP; MALE; OLIGOSACCHARIDES; PREBIOTICS; SPAIN; TRISACCHARIDES;

EID: 84896567979     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0689-9     Document Type: Article

References (40)

1. Boehm G, Moro G (2008) Structural and functional aspects of prebiotics used in infant nutrition. J Nutr 138:1818S–1828S
2. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511–521
3. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104:S1–S63
4. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G (2006) A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 91:814–819
5. Arslanoglu S, Moro GE, Boehm G (2007) Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr 137:2420–2424
6. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G (2008) Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 138:1091–1095
7. Bruzzese E, Volpicelli M, Squeglia V, Bruzzese D, Salvini F, Bisceglia M, Lionetti P, Cinquetti M, Iacono G, Amarri S, Guarino A (2009) A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study. Clin Nutr 28(2):156–161
8. Grüber C, van Stuijveberg M, Mosca F, Moro G, Chirico G, Braegger CP, Riedler J, Boehm G, Wahn U (2010) Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 126(4):791–797
9. Braegger C, Chmielewska A, Decsi T, Kolacek S, Mihatsch W, Moreno L, ESPGHAN Committee on Nutrition et al (2011) Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 52:238–250
10. Osborn DA, Sinn JK (2013) Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev 3:CD006474. doi:10.1002/14651858.CD006474.pub3
11. Schmelzle H, Wirth S, Skopnik H, Radke M, Knol J, Böckler HM, Brönstrup A, Wells J, Fusch C (2003) Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 36(3):343–351
12. Nakamura N, Gaskins HR, Collier CT, Nava GM, Rai D, Petschow B, Russell WM, Harris C, Mackie RI, Wampler JL, Walker DC (2009) Molecular ecological analysis of faecal bacterial populations from term infants fed formula supplemented with selected blends of prebiotics. Appl Environ Microbiol 75:1121–1128
13. Ben XM, Zhou XY, Zhao WH, Yu WL, Pan W, Zhang WL, Wu SM, Van Beusekom CM, Schaafsma A (2004) Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin Med J (Engl) 117:927–931
14. Fanaro S, Marten B, Bagna R, Vigi V, Fabris C, Peña-Quintana L, Argüelles F, Scholz-Ahrens KE, Sawatzki G, Zelenka R, Schrezenmeir J, de Vrese M, Bertino E (2008) Galactooligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr 48:82–88
15. Girard-Pipau F, Pompei A, Schneider S, Nano JL, Hebuterne X, Boquet P, Rampal P (2002) Intestinal microflora, short chain and cellular fatty acids, influence of a probiotic Saccharomyces boulardii. Microb Ecol Health Dis 14:220–227
16. Gueimonde M, Tölkko S, Korpimäki T, Salminen S (2004) New real-time quantitative PCR procedure for quantification of bifidobacteria in human faecal samples. Appl Environ Microbiol 70:4165–4169
17. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70:7220–7228
18. Haarman M, Knol J (2006) Quantitative real-time PCR analysis of faecal Lactobacillus species in infant receiving a prebiotic infant formula. Appl Environ Microbiol 72:2359–2365
19. Layton A, McKay L, Williams D, Garrett V, Gentry R, Sayler G (2006) Development of bacteroides 16S rRNA Gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine faecal pollution in water. Appl Environ Microbiol 72:4214–4224
20. Rinne MM, Gueimonde M, Kalliomäki M, Hoppu U, Salminen SJ, Isolauri E (2005) Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol Med Microbiol 43:59–65
21. Penders J, Vink C, Driessen C et al (2005) Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 243:141–147
22. Von Linstow ML, Holst KK, Larsen K, Koch A, Andersen PK, Hogh B (2008) Acute respiratory symptoms and general illness during the first year of life: a population-based birth cohort study. Pediatr Pulmonol 43(6):584–593
23. Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schöpfer H, Böckler HM, Wells J (2005) Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 40:36–42
24. Fukushima Y, Kawata Y, Harac H, Teradac A, Mitsuoka T (1998) Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42:39–44
25. Yasui H, Nagaoka N, Mike A, Hayakawa K, Ohwaki M (1992) Detection of Bifidobacterium strains that induce large quantities of IgA. Microb Ecol Health Dis 5:155–162
26. Topping DL, Cliftton PM (2001) Short-chain fatty acids and human colonic function: roles of resistant starch and non-starch polysaccharides. Physiol Rev 81:1031–1064
27. Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG (2005) Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr 94:783–790
28. Holscher HD, Faust KL, Czerkies LA, Litov R, Ziegler EE, Lessin H, Hatch T, Sun S, Tappenden KA (2012) Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. J Parenter Enter Nutr 36(1 Suppl):95S–105S
29. Bakker-Zierikzee AM, van Tol EAF, Kroes H, Alles MS, Kok FJ, Bindels JG (2006) Faecal IgA secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol 17:134–140
30. Scalabrin DMF, Mitmesser SH, Welling GW, Harris CL, Marunycz JD, Walker DC, Bos NA, Salminen S, Vanderhoof JA (2012) New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants. J Pediatr Gastroenterol Nutr 54:343–352
31. Edwards CA, Parrett AM, Balmer SE, Wharton BA (1994) Faecal short chain fatty acids in breast-fed and formula-fed babies. Acta Paediatr 83:459–462
32. Scholtens PA, Alliet P, Raes M, Alles MS, Kroes H, Boehm G, Knippels LM, Knol J, Vandenplas Y (2008) Faecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J Nutr 138:1141–1147
33. Xia Q, Williams T, Hustead D, Price P, Morrison M, Yu Z (2012) Quantitative analysis of intestinal bacterial populations from term infants fed formula supplemented with fructo-oligosaccharides. J Pediatr Gastroenterol Nutr 55:314–320
34. Veereman-Wauters G, Staelens S, Van de Broek H, Plaskie K, Westing F, Roger LG, McCartney AL, Assam P (2011) Physiological and bifidogenic effects of prebiotic supplements in infant formulae. J Pediatr Gastroenterol Nutr 52:763–771
35. Costalos C, Kapiki A, Apostolou M, Papathoma E (2008) The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev 84:45–49
36. Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V (2005) Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH. J Pediatr Gastroenterol Nutr 41:186–190
37. Ribeiro TCM, Costa-Ribeiro H, Almeida PS, Pontes MV, Leite M, Filadelfo L, Khoury JC, Bean JA, Mitmesser SH, Vanderhoof JA, Scalabrin DM (2012) Stool pattern changes in toddlers consuming a follow-on formula supplemented with polydextrose and galactooligosaccharides. J Pediatr Gastroenterol Nutr 54:288–290
38. Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Licciardi PV, Robins-Browne RM, Tang ML (2012) Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol 23(7):674–681
39. Singhal A, Macfarlane G, Macfarlane S et al (2008) Dietary nucleotides and faecal microbiota in formula-fed infants: a randomized controlled trial. Am J Clin Nutr 87:1785–1792
40. Field CJ, Van Aerde JE, Robinson LE, Clandinin MT (2008) Effect of providing a formula supplemented with long-chain polyunsaturated fatty acids on immunity in full-term neonates. Br J Nutr 99:91–99